Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2002

01-02-2002 | Case Report

Two Independent Clones in Myelodysplastic Syndrome Following Treatment of Acute Myeloid Leukemia

Authors: Masahiro Masuya, Naoyuki Katayama, Koichi Inagaki, Hiroshi Miwa, Natsuki Hoshino, Hiroyuki Miyashita, Hirohito Suzuki, Hiroto Araki, Hidetsugu Mitani, Kazuhiro Nishii, Shin-ichi Kageyama, Nobuyuki Minami, Hiroshi Shiku

Published in: International Journal of Hematology | Issue 2/2002

Login to get access
Metadata
Title
Two Independent Clones in Myelodysplastic Syndrome Following Treatment of Acute Myeloid Leukemia
Authors
Masahiro Masuya
Naoyuki Katayama
Koichi Inagaki
Hiroshi Miwa
Natsuki Hoshino
Hiroyuki Miyashita
Hirohito Suzuki
Hiroto Araki
Hidetsugu Mitani
Kazuhiro Nishii
Shin-ichi Kageyama
Nobuyuki Minami
Hiroshi Shiku
Publication date
01-02-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982025

Other articles of this Issue 2/2002

International Journal of Hematology 2/2002 Go to the issue

OriginalPaper

Comparison of Pgp- and MRP-Mediated Multidrug Resistance in Leukemia Cell Lines

Case Report

Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis

OriginalPaper

Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

OriginalPaper

Risk of Etoposide-Related Acute Myeloid Leukemia in the Treatment of Epstein-Barr Virus—Associated Hemophagocytic Lymphohistiocytosis

Case Report

Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy

OriginalPaper

Stem Cell Transplantation for Aplastic Anemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits